Table 1

Characteristics of clinicians who submitted input to the pan-Canadian Oncology Drug Review

Characteristics of individual clinicians consulted
Total number of clinician feedback submissions342 (100)
Unique clinicians129 (100)
Number of funding decisions consulted
 176 (59)
 216 (12)
 3–1033 (26)
 More than 104 (3)
Affiliation
 Physician124 (96)
 Oncology pharmacist5 (4)
Characteristics of clinician group submissions
Reimbursement decisions (2016–2020)62 (100)
Reimbursement decisions with clinician submissions*48 (100)
Clinician recommendation
 Fund46 (96)
 Do not fund2 (4)
Median number of clinicians who offered feedback per drug review (IQR)4 (2–8)
  • *Study sample.